Duo Oncology logo

Duo Oncology

Nanomedicines as the foundation of cancer medicine. Platform chemistry designed for patients.

4 employees · est. 2020 · Pittsburgh, United States

VS
Elephas logo

Elephas

Live tumor profiling for immunotherapy response prediction

145 employees · est. 2020 · Madison, United States

Elephas is the larger of the two.

Side-by-Side Comparison

Duo Oncology Elephas
Founded
2020 2020
Headquarters
Pittsburgh, United States Madison, United States
Employees
4 145 larger
Industry
Biotechnology, Pharmaceutical AI, Biotechnology, Health Care
Funding Stage
Seed Series C
Total Funding
$3.00M $178.50M
Funding Rounds
1 6
Services
Development of Nanomedicines, Cancer Therapy Innovation, Drug Approval Processes, Platform for Drug Delivery Elephas Live Platform, Immunotherapy Response Prediction, Functional Testing of Live Tissue, Data Aggregation and Analysis
Target Customers
Cancer Patients, Oncologists, Pharmaceutical Companies Pathology Labs, Healthcare Providers, Cancer Researchers, Biotechnology Companies
Taxonomy
Nanomedicine, Oncology, Tumor-penetration, Prodrug Chemistry, Nanoparticle Technology, Cancer Treatment, Pharmaceutical Development, Drug Delivery Systems, Patient Outcomes, Tumor-targeting, University Collaboration, Medical Oncology, Research Partnerships, Lean Pharma Business Ex-vivo Platform, Tumor Profiling, Immunotherapy Response Prediction, Live Patient Biopsies, Tumor Microenvironment, Tumor Heterogeneity, Real-time Immune Characterization, Oncology Diagnostics, Patient-centric Solutions, Cancer Biology, Multimodal Microscopy, Clinical Decision-making, Drug Development, Oncology Innovation
Website
duooncology.com elephas.com
Duo Oncology logo

About Duo Oncology

Duo Oncology, founded in 2020 by oncologists, is making strides in the Biotechnology and Pharmaceutical industries. Headquartered in the United States, the company is focusing on developing tumor-penetrating nanomedicines, which it claims will upgrade the foundations of cancer medicine. At the heart...

Elephas logo

About Elephas

Elephas, founded in 2020 and headquartered in the United States, is making significant strides in the intersection of AI, Biotechnology, and Health Care. The company's slogan, "Live tumor profiling for immunotherapy response prediction," highlights its core innovation: an ex-vivo platform that analy...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Duo Oncology and Elephas — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Duo Oncology and Elephas — by email.

Frequently Asked Questions

Duo Oncology — Nanomedicines as the foundation of cancer medicine. Platform chemistry designed for patients. . Elephas — Live tumor profiling for immunotherapy response prediction. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Duo Oncology has raised $3.00M while Elephas has raised $178.50M.
Duo Oncology and Elephas operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Duo Oncology with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy